1. Home
  2. MDGL vs PHYS Comparison

MDGL vs PHYS Comparison

Compare MDGL & PHYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • PHYS
  • Stock Information
  • Founded
  • MDGL 2011
  • PHYS N/A
  • Country
  • MDGL United States
  • PHYS
  • Employees
  • MDGL N/A
  • PHYS N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • PHYS
  • Sector
  • MDGL Health Care
  • PHYS
  • Exchange
  • MDGL Nasdaq
  • PHYS NYSE
  • Market Cap
  • MDGL 7.4B
  • PHYS 8.5B
  • IPO Year
  • MDGL N/A
  • PHYS N/A
  • Fundamental
  • Price
  • MDGL $308.44
  • PHYS $20.20
  • Analyst Decision
  • MDGL Buy
  • PHYS
  • Analyst Count
  • MDGL 14
  • PHYS 0
  • Target Price
  • MDGL $347.33
  • PHYS N/A
  • AVG Volume (30 Days)
  • MDGL 355.8K
  • PHYS N/A
  • Earning Date
  • MDGL 10-31-2024
  • PHYS N/A
  • Dividend Yield
  • MDGL N/A
  • PHYS N/A
  • EPS Growth
  • MDGL N/A
  • PHYS N/A
  • EPS
  • MDGL N/A
  • PHYS N/A
  • Revenue
  • MDGL $76,813,000.00
  • PHYS N/A
  • Revenue This Year
  • MDGL N/A
  • PHYS N/A
  • Revenue Next Year
  • MDGL $194.49
  • PHYS N/A
  • P/E Ratio
  • MDGL N/A
  • PHYS N/A
  • Revenue Growth
  • MDGL N/A
  • PHYS N/A
  • 52 Week Low
  • MDGL $168.25
  • PHYS N/A
  • 52 Week High
  • MDGL $368.29
  • PHYS N/A
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 51.11
  • PHYS 45.98
  • Support Level
  • MDGL $289.80
  • PHYS $20.17
  • Resistance Level
  • MDGL $315.09
  • PHYS $20.98
  • Average True Range (ATR)
  • MDGL 12.44
  • PHYS 0.16
  • MACD
  • MDGL -4.11
  • PHYS -0.03
  • Stochastic Oscillator
  • MDGL 48.58
  • PHYS 27.98

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

About PHYS SPROTT PHYSICAL GOLD TRUST

Sprott Physical Gold Trust is a closed-end mutual fund trust. The company provides a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical gold bullion without the inconvenience associated with direct investment in physical gold bullion. The company invests mainly in long-term holdings of unencumbered, fully allocated, physical gold bullion and does not and will not speculate about short-term changes in gold prices.

Share on Social Networks: